ERIKA FROMHOLD: Open Payments
NPI 1417476060 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 35 payments from 13 companies in 2025. Trend: 2023 $757 · 2024 $759 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $257 |
| Novo Nordisk Inc | 4 | $173 |
| Boston Scientific Corporation | 1 | $142 |
| Amgen Inc. | 2 | $137 |
| Aimmune Therapeutics, Inc. | 2 | $126 |
| Lilly USA, LLC | 1 | $125 |
| GlaxoSmithKline, LLC. | 5 | $107 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
Products named: UBRELVY, JARDIANCE, Ozempic, General - Therapies, EVENITY, ZENPEP, QULIPTA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
